Jian-yong Wang
P.R. China
Binzhou, 256603, China
Binzhou, 256603, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.
Journal: International journal of oncology
Published: August 07, 2016
Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Journal: International journal of oncology
Published: January 07, 2016
Osthole shows the potential to overcome P-glycoprotein‑mediated multidrug resistance in human myelogenous leukemia K562/ADM cells by inhibiting the PI3K/Akt signaling pathway.
Journal: Oncology reports
Published: December 07, 2015
Effects of safflower injection on HEL leukemia cell proliferation and apoptosis and relevant molecular mechanisms
Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Published: September 29, 2015
Determination of Th9 cells and IL-9 in children with Mycoplasma pneumoniae infection
Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Published: April 29, 2015
Inhibition of Forkhead box protein M1 by thiostrepton increases chemosensitivity to doxorubicin in T-cell acute lymphoblastic leukemia.
Journal: Molecular medicine reports
Published: June 13, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026